Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

  • This share is currently suspended. It was suspended at a price of 72.80
  • There is currently no data for SPA

Directorate Change

22 Jul 2010 15:01

RNS Number : 7833P
Avisen PLC
22 July 2010
 



Avisen plc

 

Directorate Change

 

Avisen PLC (the "Company") the AIM-quoted technology consultancy specialising in performance management, is pleased to announce that Jonathan Hill has been appointed to the board of the Company as Chief Operating Offer with immediate effect.

 

For further information:

 

Avisen PLC

Marcus Hanke, CEO

Claire Milverton, Interim CFO

 

0870 880 2978

Brewin Dolphin

Matt Davis

Neil McDonald

0845 213 1000

 

Pursuant to the AIM Rules for Companies (the "AIM Rules"), the following information in respect of Jonathan Hill required to be disclosed is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule 2 of the AIM Rules.

 

Full name and age

Jonathan Charles George Hill (41)

Current shareholding in the Company

Mr Hill has a beneficial interest in 4,026,011 ordinary shares of 5p each in the Company

Current Directorships and Partnerships

Wexner Global Limited

Previous Directorships and Partnerships

Wexner Limited

Clement Property Restoration LLP

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUUUMUPUGCP
Date   Source Headline
19th Jan 20063:11 pmRNSProduct Launch
12th Jan 200611:17 amRNSInvestor Presentation
11th Jan 20067:00 amRNSProduct Launch
28th Nov 20057:00 amRNSRe Agreement
21st Nov 20057:02 amRNSInterim Results
7th Nov 20057:00 amPRNRetail Agreement
18th Oct 20052:14 pmPRNNotice of Results
26th Sep 20057:00 amRNSProduct Launch
2nd Sep 20051:03 pmRNSRetail Distribution
24th Jun 20056:00 amPRNRetail Agreement
21st Jun 20058:00 amRNSFirst day of dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.